PMID: 8597969Jan 1, 1995Paper

Pharmacokinetics of alcuronium in children with acyanotic and cyanotic cardiac disease undergoing cardiopulmonary bypass surgery

Paediatric Anaesthesia
L M WeekesI M Ramzan

Abstract

The aim of this study was to determine the pharmacokinetic parameters for alcuronium in children with cyanotic or acyanotic congenital cardiac disease undergoing cardiopulmonary bypass surgery and to compare these parameters with previously reported values in children and adults with normal cardiac function. Seven children with acyanotic disease and seven with cyanotic disease were studied. Alcuronium (base) was administered in an initial dosage of 0.25 mg.kg-1 with additional doses as needed to maintain paralysis. Using time averaged data, cyanotic children had lower mean clearance, elimination half-life and volume of distribution at steady state than the acyanotic children; none of these differences was, however, statistically significant. In this study, children with acyanotic and cyanotic cardiac disease undergoing bypass, had a diminished clearance (P < 0.05) and a smaller volume of distribution (P < 0.05) than normal children and a shorter elimination half-life (P < 0.05) than adults. Onset of cardiopulmonary bypass caused an immediate marked decrease in alcuronium plasma concentrations which remained low in the acyanotic children at the completion of bypass.

References

Feb 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·K C Yeh, K C Kwan
Jan 1, 1979·Clinical Pharmacology and Therapeutics·R G McAllisterE P Todd
Feb 1, 1983·British Journal of Clinical Pharmacology·J S WalkerC A Shanks
Jan 1, 1984·Clinical Radiology·F SchubertJ S Harper
May 1, 1984·Clinical Pharmacology and Therapeutics·J S WalkerK F Brown
Jan 1, 1983·British Journal of Clinical Pharmacology·E S Paykel
May 1, 1982·Clinical Pharmacokinetics·F O HolleyD R Stanski
Nov 1, 1981·Anesthesia and Analgesia·E L Maunuksela, R I Gattiker
Jan 1, 1980·Contemporary Anesthesia Practice
Apr 1, 1980·Clinical Pharmacology and Therapeutics·K W MillerD E Zaske
Feb 1, 1993·Critical Care Medicine·R T Mathie
Jan 1, 1993·Journal of Clinical Pharmacology·M A SirgoS Walker
Apr 1, 1993·Anaesthesia·D J Bihari, R W Chang
Apr 1, 1993·Anaesthesia and Intensive Care·J P KeneallyI M Ramzan

❮ Previous
Next ❯

Citations

May 1, 1997·Journal of Cardiothoracic and Vascular Anesthesia·D A Rosen, K R Rosen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.